1 Min Read
May 5 (Reuters) - PDL BioPharma Inc
* Lensar® receives FDA clearances for laser cataract platform integration with Oculus Pentacam® Tomographers Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.